对口腔白血病的随机对照试验
Michele Lodolo1, Jack Valor2, Alessandro Villa1,2
1Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, California, USA.
Oral diseases
|June 3, 2025
概括
新兴的口腔白血病治疗方法,包括局部药物和激光疗法,在预防长期复发或恶性转变方面表现出有限的成功. 对于有效的口腔白血病管理,需要进一步的研究.
科学领域:
- 口腔医学是指口腔医学.
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 口腔白血病呈现为白色斑块,具有恶性转变的显著风险.
- 目前的切除和激光切除等治疗方法存在局限性,包括复发和持久性恶性潜在.
研究的目的:
- 审查2014年至2024年期间发表的关于口腔白血病新兴治疗策略的随机对照试验 (RCT).
- 确定新的治疗方法,并评估它们在治疗口腔白血病和预防恶性进展方面的有效性.
主要方法:
- 对口服白血病治疗的7项随机对照试验进行了系统审查.
- 研究评估了包括局部Moringa oleifera,黄素,带有维生素C的β-胡卜素,手术切除,激光切除和光动力学治疗在内的干预措施.
主要成果:
- 一些评估的干预措施表明,减少了病变大小和短期复发率.
- 没有一项经过审查的治疗策略在预防口腔白血病的长期复发或恶性转变方面被证明有效.
- 这些可用的RCT数据有限.
结论:
- 目前针对口腔白血病的新兴治疗方法在长期结果方面提供了有限的好处.
- 进一步的大规模,严格设计的随机对照试验对于建立有效的管理策略至关重要.
- 对于预防口腔白血病患者恶性转变的新疗法的需求尚未得到满足.
相关概念视频
01:13Randomized Experiments
8.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.9K
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K